Fat-Modifying Enzyme May Be Key to Cancer and Metabolic Diseases

The tight regulation of lipid production within cells could be critical in the development of diseases such as obesity, diabetes, and even cancer. The enzyme phosphatidic acid phosphatase (PAP) has been known for decades to have a critical function in regulating the amount of fat in the human body. Yet now, scientists at Rutgers University-New Brunswick have found that abrogation of the enzyme entirely could increase the risk of cancer, inflammation, and a host of other aberrant cellular process